Plandaí Biotechnology logo

Plandaí Biotechnology(OTC) PLPL

Market Cap$44.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2011)-100%
5 Year-100%
1 Year+0%
1 Month+0%
$0.00
+0.00%
+0.00Today
Plandaí Biotechnology last closing stock price
MetricPriceDate
Last closeUSD 0.002026-10-08
Plandaí Biotechnology stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-09-28
1 month+0%USD 0.002026-09-08
3 month+0%USD 0.002026-07-10
Year to date-99%USD 0.002025-12-31
1 year+0%USD 0.002025-10-08
3 year-99%USD 0.002023-10-09
5 year-99.92%USD 0.002021-10-08
Since inception-100%USD 0.212011-11-18

Plandaí Biotechnology Financials at a Glance

Market Cap

$44.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

-$51.40K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

63.53 (High)

Price

$0.00

Volume

2,000,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

PLPL News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Plandaí Biotechnology

Plandaí Biotechnology, Inc. is a biotechnology company based in Taipei, Taiwan. The company has historically been involved in biotechnology-related operations but currently does not have significant operations.

Products and Services
  • Focus on biotechnology applications
  • Research and development in health-related products
  • Potential future product offerings in the wellness sector
Growth Outlook
  • Market cap of approximately $4.49 million indicates potential for growth
  • Company has a beta of 9.728, suggesting high volatility and opportunity
  • Current stock price range shows potential for upward movement
Financial Highlights
  • Recent quarterly net income of -$849, indicating ongoing operational challenges
  • Trailing twelve months (TTM) revenue remains at $0, highlighting need for strategic direction
  • Operating expenses totaled $80,000 in the latest quarter, reflecting cost management issues
Plandaí Biotechnology, Inc. operates in a challenging environment with no current revenue generation. The company’s focus on biotechnology applications and potential future product offerings may present opportunities for growth. However, the financial data indicates significant operational losses and a need for strategic planning to enhance performance. The high beta suggests that the stock may experience considerable price fluctuations, which could attract investors looking for high-risk, high-reward opportunities.
AI Generated • Sep 26, 2026

Industry

Biotechnology

Sector

Health Care

Employees

3

CEO

Yi-Kuan Lin

Website

www.diamondranchfoods.com

Headquarters

Taipei, TP 330, TW

PLPL Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

0.00%

Return on Capital

-51.40%

Return on Assets

0.00%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$44.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

44.89B

Volume

2.00M

Avg. Volume

3.42M

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$51.40K

EBITDA

-$51.40K

Operating Cash Flow

$15.64M

Capital Expenditure

-$3.12

Free Cash Flow

$15.64M

Cash & ST Invst.

$0.00

Total Debt

$158.78K

Plandaí Biotechnology Performance Analysis

Plandaí Biotechnology annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-06-30USD 0N/A
20242024-06-30USD 0N/A
20252025-06-30USD 0N/A
20262026-06-30USD 0N/A
Plandaí Biotechnology sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-09-30N/A
Q22025-12-31N/A
Q32026-03-31N/A
Q42026-06-30N/A
Plandaí Biotechnology annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-06-30USD -0.00N/A
20242024-06-30USD 0.00N/A
20252025-06-30USD 0.00N/A
20262026-06-30USD 0.00N/A
Plandaí Biotechnology sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-09-30N/A
Q22025-12-31N/A
Q32026-03-31N/A
Q42026-06-30N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$44.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$249.44

N/A

Employees

180

N/A

Net Income

-$13.23K

+39.8%

EBITDA

-$13.32K

+39.3%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

$0.00

N/A

Total Debt

$158.78K

+216.5%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$100.00K

N/A

Short Term Debt

$58.78K

+17.1%

Return on Assets

0.00%

N/A

Return on Invested Capital

0.00%

N/A

Free Cash Flow

$15.82M

+3858041.2%

Operating Cash Flow

$15.82M

+3858042.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AGSSAmeriguard Security Services, Inc.
$0.01+22.00%
CBTCXTRA Bitcoin Inc.
$0.00+2.94%
TGGITrans Global Group, Inc.
$0.00+0.00%
ARATArax Holdings Corp.
$0.02+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$12.67-0.94%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$33.79+10.24%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$142.52-10.31%
SPCXSpace Exploration Technologies
$160.57-4.20%

Questions About PLPL

What is the current price of Plandaí Biotechnology?

Plandaí Biotechnology is trading at $0.00 per share.

What is the 52-week range for Plandaí Biotechnology?

Over the past 52 weeks, Plandaí Biotechnology has traded between $0.00 and $0.00.

How much debt does Plandaí Biotechnology have?

As of the most recent reporting period, Plandaí Biotechnology reported total debt of $95.78K.

How much cash does Plandaí Biotechnology have on hand?

Plandaí Biotechnology reported $0.00 in cash and cash equivalents in its most recent financial results.

What is Plandaí Biotechnology’s dividend yield?

Plandaí Biotechnology does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services